RP Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-980,392
| Closed | -$39.4M | – | 3 |
|
|
2025
Q1 | $39.4M | Hold |
980,392
| – | – | 28.38% | 2 |
|
|
2024
Q4 | $51.8M | Hold |
980,392
| – | – | 22.73% | 2 |
|
|
2024
Q3 | $51.8M | Hold |
980,392
| – | – | 22.73% | 2 |
|
|
2024
Q2 | $53.1M | Buy |
+980,392
| New | +$53.1M | 29.71% | 2 |
|
|
2021
Q2 | – | Sell |
-875,656
| Closed | -$20.4M | – | 4 |
|
|
2021
Q1 | $20.4M | Hold |
875,656
| – | – | 7.65% | 3 |
|
|
2020
Q4 | $18.2M | Hold |
875,656
| – | – | 5.58% | 3 |
|
|
2020
Q3 | $19M | Hold |
875,656
| – | – | 2.84% | 4 |
|
|
2020
Q2 | $20.6M | Hold |
875,656
| – | – | 3.99% | 4 |
|
|
2020
Q1 | $10.3M | Hold |
875,656
| – | – | 3.21% | 4 |
|
|
2019
Q4 | $9.29M | Hold |
875,656
| – | – | 2.1% | 4 |
|
|
2019
Q3 | $9.97M | Hold |
875,656
| – | – | 6.38% | 3 |
|
|
2019
Q2 | $9.85M | Hold |
875,656
| – | – | 6.04% | 3 |
|
|
2019
Q1 | $7.08M | Hold |
875,656
| – | – | 3.54% | 3 |
|
|
2018
Q4 | $5.53M | Buy |
+875,656
| New | +$5.53M | 3.79% | 3 |
|